Most recent update: Thursday, April 18, 2019 - 10:50
You are here
%2 News
30/03/19 -
Research
PIONEER 3 outcomes
Oral semaglutide 7mg and 14mg demonstrated superior HbA1c and body weight reductions compared to Januvia (sitagliptin 100mg), although non-inferiority for oral semaglutide 3mg for HbA1c reductions at...
27/03/19 -
Research
Post-bariatric hypoglycaemia
A new automated drug delivery system can help prevent dangerously low blood sugar in patients who have undergone weight-loss surgery, according to a study, ‘OR22-3: Closed-Loop Glucagon Pump: A Novel...
22/03/19 -
Research
Learning curve
Bariatric fellowships reduce the learning curve for laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) and helps to achieve excellent outcomes in the first and over seven years of independent...
13/03/19 -
Research
Access to surgery
There is very little difference in access to bariatric surgery in Sweden with regards to socioeconomic status among patients with BMI>40, according to researchers from Lund University, Lund,...
08/03/19 -
Research
Genetics and obesity
Researchers from Rockefeller University and collaborators have identified a genetic mechanism that may play a role in at least 10 percent of all obesity cases. The findings, which could help identify...
- 1 of 41
- next ›
18/04/19 -
Research
Rheumatic disorders and surgery
A literature review by researchers looking at the complex relationship between obesity, various rheumatic diseases and bariatric surgery has underscored the need to establish long-term prospective...
16/04/19 -
Research
Cognitive functioning and surgery
Young people with cognitive impairments and developmental disabilities (CI/DD), including Down syndrome, have similar weight-loss trajectories to those with typical cognitive function after bariatric...
16/04/19 -
Industry
Product approval
Gelesis has gained FDA approval for its lead product candidate, PLENITY (Gelesis100), as an aid in weight management in adults with a BMI25–40, when used in conjunction with diet and exercise....
